NCT04379739 2023-12-06Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung CancerShanghai Pulmonary Hospital, Shanghai, ChinaPhase 2 Active not recruiting89 enrolled